AMLX
Amylyx Pharmaceuticals Inc
33.00$
+1.9%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.4% | 96.7% | 99.4% | 97.6% | 89.8% | 97.8% | 97.3% | |
| 95.2% | 91.3% | 47.5% | 16.0% | 32.9% | 40.0% | 68.1% | |
| 95.2% | 91.3% | 91.0% | 88.6% | 71.8% | 91.2% | 95.3% | |
| – | – | 0.0% | 3.9% | 7.7% | 0.2% | 0.0% | |
| – | – | 0.0% | 2.5% | 7.4% | 0.0% | – | |
| – | 1.1% | 0.4% | 0.7% | – | – | – | |
| 887.5% | 573.1% | 243.1% | 13.0% | 16.2% | 14.9% | 8.2% | |
| 140.7% | 51.9% | 16.5% | 11.9% | 15.9% | 14.7% | 6.8% | |
| – | – | – | 0.5% | 0.4% | 0.8% | 0.4% | |
| 68.2% | 25.6% | 4.1% | 1.6% | 4.3% | 1.5% | 1.1% | |
| 463.7% | 10.1% | – | – | – | – | – | |
| -787.5% | -473.1% | -143.1% | 87.0% | 83.8% | 85.1% | 91.8% | |
| -796.1% | -481.5% | -147.6% | -90.5% | -58.9% | -313.3% | -225.9% | |
| 1,753.6% | 400.4% | 54.8% | 17.0% | 13.5% | 35.2% | 28.4% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.